Articles

Sort by
Previous Page Page 1 of 4 Next Page
  1. Research

    Timing-adjusted iron dosing enhances erythropoiesis-stimulating agent-induced erythropoiesis response and iron utilization

    We recently demonstrated, using an index of recently synthesized hemoglobin, reticulocyte hemoglobin (Ret-Hb), that iron administration remarkably improves hemoglobin (Hb) synthesis during the period of high a...

    Tomoyuki Kawano, Tadashi Kuji, Tetsuya Fujikawa, Eiko Ueda, Midori Shino, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura, Nobuhito Hirawa and Yoshiyuki Toya

    Renal Replacement Therapy 2017 3:20

    Published on: 22 May 2017

  2. Position statement

    Annual peritoneal dialysis report 2014, the peritoneal dialysis registry

    Since 2009, the peritoneal dialysis (PD) registry has been carried out as part of Japanese Society for Dialysis Therapy (JSDT) Renal Data Registry with the cooperation of Japanese Society for Peritoneal Dialys...

    Ikuto Masakane, Takeshi Hasegawa, Satoshi Ogata, Naoki Kimata, Shigeru Nakai, Norio Hanafusa, Takayuki Hamano, Kenji Wakai, Atsushi Wada and Kosaku Nitta

    Renal Replacement Therapy 2017 3:21

    Published on: 15 May 2017

  3. Position statement

    Policy for developing clinical practice guidelines of Japanese Society for Dialysis Therapy

    The Scientific Academy Committee of Japanese Society for Dialysis Therapy (JSDT) has developed 14 clinical practice guidelines (CPGs) and their revised editions independently or in cooperation with other organ...

    Kosaku Nitta, Ikuto Masakane, Tadashi Tomo, Kenji Tsuchida, Kiyoshi Ikeda, Tomonari Ogawa, Eiichiro Kanda, Yoshihiko Kanno, Yasuhiro Komatsu, Masatomo Taniguchi, Fumika Taki, Takeshi Hasegawa, Norio Hanafusa, Takayuki Hamano, Masafumi Fukagawa, Jun Minakuchi…

    Renal Replacement Therapy 2017 3:34

    Published on: 11 May 2017

  4. Review

    Peritonitis-induced peritoneal injury models for research in peritoneal dialysis review of infectious and non-infectious models

    Peritonitis is an important complication of peritoneal dialysis. Several animal peritonitis models have been described, including bacterial and fungal models that are useful for studying inflammation in perito...

    Yasuhiko Ito, Hiroshi Kinashi, Takayuki Katsuno, Yasuhiro Suzuki and Masashi Mizuno

    Renal Replacement Therapy 2017 3:16

    Published on: 1 May 2017

  5. Research

    Efficacy of Saxagliptin versus Mitiglinid in patients with type 2 diabetes and end-stage renal disease

    There are very few oral antidiabetic drugs recommended for patients on dialysis. Saxagliptin is known for its potent effect and long duration of action. In this study, we compared the efficacy of Saxagliptin w...

    Yukinao Sakai, Saori Sakai, Koji Mugishima, Anna Katayama, Yuichiro Sumi, Yusuke Otsuka, Tomoyuki Otsuka and Shuichi Tsuruoka

    Renal Replacement Therapy 2017 3:15

    Published on: 24 April 2017

  6. Case Report

    Poor glycemic control attributable to insulin antibody in a fulminant type 1 diabetes patient under hemodialysis: successful treatment with double filtration plasmapheresis and prednisolone

    Insulin antibody appears in approximately 40% of insulin users using human insulin and insulin analog formulations. Insulin antibody, characterized by high affinity and low insulin antibody binding capacity (%...

    Kentaro Wada, Haruhito A. Uchida and Yuko Wada

    Renal Replacement Therapy 2017 3:14

    Published on: 17 April 2017

  7. Review

    Atypical hemolytic uremic syndrome

    Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy (TMA) characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Most cases of aHUS are caused by u...

    Yoko Yoshida, Hideki Kato and Masaomi Nangaku

    Renal Replacement Therapy 2017 3:5

    Published on: 3 April 2017

  8. Research

    Effect of continuous hemodiafiltration using an AN69ST membrane in patients with sepsis

    Sepsis is a systemic inflammatory response syndrome caused by infectious disease. Severe sepsis and septic shock are extremely serious conditions with poor prognoses. It is reported that cytokines are deeply i...

    Akihito Tanaka, Daijo Inaguma, Tomoaki Nakamura, Yu Watanabe, Eri Ito, Naoki Kamegai, Hiroya Shimogushi, Minako Murata, Hibiki Shinjo, Kiyomi Koike, Yasuhiro Otsuka and Asami Takeda

    Renal Replacement Therapy 2017 3:12

    Published on: 27 March 2017

  9. Research

    Effect of cardiovascular risk factors and time of hospital presentation on mortality of maintenance hemodialysis patients presenting with acute pulmonary edema

    Acute pulmonary edema (APE) has a poor prognosis in the general population. Mortality associated with APE in patients with end-stage renal disease (ESRD) is especially high, although specific predictors are no...

    Saki Hasegawa, Shintaro Nakano, Jun Tanno, Shiro Iwanaga, Ritsushi Kato, Toshihiro Muramatsu, Yusuke Watanabe, Hirokazu Okada, Takaaki Senbonmatsu, Hidetomo Nakamoto and Shigeyuki Nishimura

    Renal Replacement Therapy 2017 3:8

    Published on: 20 March 2017

  10. Research

    Virological response to daclatasvir and asunaprevir combination therapy for chronic hepatitis C virus genotype 1b infection in dialysis patients: a prospective, multicenter study

    The introduction of direct-acting antiviral agents (DAAs) for the treatment of chronic hepatitis C virus (HCV) infection in patients undergoing hemodialysis (HD) has improved sustained virological response (SV...

    Haruki Uojima, Shuzo Kobayashi, Hisashi Hidaka, Shuichi Matsumoto, Takayasu Ohtake, Takeshi Kinbara, Machiko Oka, Yasuhiro Yamanouchi, Takehiko Kunieda, Hiroki Yamanoue, Takayuki Kanemaru, Kazuhiko Tsutsumi, Tomoaki Fujikawa, Ji Hyun Sung and Makoto Kako

    Renal Replacement Therapy 2017 3:7

    Published on: 13 March 2017

  11. Research

    Efficacy of tonsillectomy for the treatment of immunoglobulin A nephropathy recurrence after kidney transplantation

    Post-transplant recurrent nephritis is the third common complication that leads to graft loss, which affects the long-term graft survival of kidney transplant patients. Immunoglobulin A nephropathy (IgAN) is t...

    Hiroshi Nihei, Ken Sakai, Seiichiro Shishido, Kazutoshi Sibuya, Hideo Edamatsu and Atsushi Aikawa

    Renal Replacement Therapy 2017 3:10

    Published on: 6 March 2017

  12. Position statement

    Annual Dialysis Data Report 2014, JSDT Renal Data Registry (JRDR)

    The Japanese Society for Dialysis Therapy (JSDT) has performed a nationwide renal data registry since 1966. The data from the survey have been used for promoting dialysis facilities to improve dialysis quality...

    Ikuto Masakane, Shigeru Nakai, Satoshi Ogata, Naoki Kimata, Norio Hanafusa, Takayuki Hamano, Kenji Wakai, Atsushi Wada and Kosaku Nitta

    Renal Replacement Therapy 2017 3:18

    Published on: 24 February 2017

  13. Research

    Serum albumin level adjusted with C-reactive protein predicts hemodialysis patient survival

    Malnutrition-related conditions such as protein energy wasting are affecting poor outcome of the dialysis population. The serum albumin level is often used as a marker of wasting and malnutrition. However, the...

    Norio Hanafusa, Kosaku Nitta, Masayuki Okazaki, Mizuki Komatsu, Shunji Shiohira, Hiroshi Kawaguchi and Ken Tsuchiya

    Renal Replacement Therapy 2017 3:9

    Published on: 20 February 2017

  14. Review

    Histopathological findings in transplanted kidneys

    Improvements in immunosuppression have reduced acute kidney allograft rejection and clinicians are now seeking ways to prolong allograft survival to 20 years and beyond. The primary cause of kidney allograft l...

    Ai Katsuma, Takafumi Yamakawa, Yasuyuki Nakada, Izumi Yamamoto and Takashi Yokoo

    Renal Replacement Therapy 2017 3:6

    Published on: 16 February 2017

  15. Research

    Higher reticulocyte counts are associated with higher mortality rates in hemodialysis patients: a retrospective single-center cohort study

    We assessed laboratory data related to mortality in hemodialysis (HD) patients. In our preliminary study, we examined all of the data for HD outpatients in our facility according to whether the patient had sur...

    Chieko Takagi, Kumeo Ono, Hidenori Matsuo, Nobuo Nagano and Yoshihisa Nojima

    Renal Replacement Therapy 2017 3:4

    Published on: 13 February 2017

  16. Position statement

    Present status of renal replacement therapy at 2015 in Asian countries (Myanmar, Vietnam, Thailand, China, and Japan)

    Currently, the Asian region is showing marked population growth and economic progress. In developing countries in Asia, rapid demands for dialysis therapy which have the same standard as those delivered in dev...

    Toru Hyodo, Nobuhito Hirawa, Matsuhiko Hayashi, Khin Maung Maung Than, Do Gia Tuyen, Korntip Pattanasittangkur, Liu Wen Hu, Tomotaka Naramura, Kenichi Miyamoto and Akihiro C. Yamashita

    Renal Replacement Therapy 2017 3:11

    Published on: 27 January 2017

  17. Case Report

    Effectiveness case of Jidabokuippo (traditional Japanese Kampo medicine) on pain, venous thrombosis, and subcutaneous hematoma after percutaneous femoral catheterization in a hemodialysis patient

    The authors herein report a case of pain, femoral vein thrombosis, and inguinal subcutaneous hematoma caused by percutaneous femoral vascular catheterization in a hemodialysis (HD) patient complicated with vas...

    Kentaro Wada, Haruhito A. Uchida and Yuko Wada

    Renal Replacement Therapy 2017 3:3

    Published on: 23 January 2017

  18. Case Report

    A case of rapid progression of Fabry nephropathy with remarkable glomerulomegaly: a case report and mini literature review of weak response to enzyme replacement therapy (ERT)

    Fabry disease is a rare X-linked hereditary disorder (Xq22) caused by a deficiency in alpha-galactosidase (α-GAL) activity. This enzyme deficit results in the systemic accumulation of glycophospholipids, leadi...

    Ayako Saito, Tomoyoshi Kimura, Yoichi Takeuchi, Ken Matsuda, Hirotaka Fukami, Hiroyuki Sato, Yoshitsugu Iwakura, Hiroshi Sato and Tasuku Nagasawa

    Renal Replacement Therapy 2017 2:69

    Published on: 9 January 2017

  19. Research

    Risk factors for erectile dysfunction in end-stage renal disease patients with short- or long-term hemodialysis therapy

    The influence of prolongation of hemodialysis (HD) period for erectile dysfunction (ED) has not been well evaluated. We evaluated the effects of various factors including hemodialysis duration for ED in hemodi...

    Hayato Nishida, Atsushi Yamagishi, Toshihiko Sakurai, Tomohiro Shibasaki, Hisashi Kawazoe, Osamu Ichiyanagi, Tomoyuki Kato, Akira Nagaoka, Yoshihiko Tomita and Norihiko Tsuchiya

    Renal Replacement Therapy 2016 2:65

    Published on: 22 December 2016

Previous Page Page 1 of 4 Next Page